The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes in refractory aggressive diffuse large b-cell lymphoma (DLBCL): Results from the international SCHOLAR-1 study.
 
Michael Crump
No Relationships to Disclose
 
Sattva Swarup Neelapu
Research Funding - Kite, a Gilead company
 
Umar Farooq
Research Funding - Kite, a Gilead company (Inst)
 
Eric Van Den Neste
No Relationships to Disclose
 
John Kuruvilla
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Lundbeck; Merck; Roche; Seagen
Research Funding - Celgene; Karyopharm Therapeutics; Roche
 
Mohamed Amin Ahmed
No Relationships to Disclose
 
Brian K. Link
Research Funding - Kite, a Gilead company (Inst)
 
Annette E. Hay
No Relationships to Disclose
 
James Robert Cerhan
Research Funding - Kite, a Gilead company (Inst)
 
Liting Zhu
No Relationships to Disclose
 
Sami Boussetta
No Relationships to Disclose
 
Lei Feng
No Relationships to Disclose
 
Matthew John Maurer
No Relationships to Disclose
 
Lynn Navale
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Amgen; Kite, a Gilead company
 
Jeffrey S. Wiezorek
Employment - Kite, a Gilead company
Leadership - Kite, a Gilead company
Stock and Other Ownership Interests - Kite, a Gilead company
 
William Y. Go
Employment - Kite, a Gilead company
Stock and Other Ownership Interests - Amgen; Kite, a Gilead company
 
Christian Gisselbrecht
Speakers' Bureau - Roche/Genentech
Research Funding - Roche/Genentech (Inst)